From: Assessment of plasminogen activator inhibitor-1 in obese Egyptian children
PAI-1 in obese group | R | p |
---|---|---|
Height (cm) | 0.2 | 0.3 |
Height (SDS) | 0.1 | 0.4 |
Weight (kg) | 0.6 | 0.000** |
Weight (SDS) | 0.2 | 0.3 |
BMI (kg/m2) | 0.6 | 0.000** |
BMI (SDS) | 0.4 | 0.01* |
Waist circumference (cm) | 0.09 | 0.6 |
Hip circumference (cm) | 0.1 | 0.4 |
W/H ratio | 0.7 | 0.000** |
Biceps skin fold (mm) | 0.4 | 0.03* |
Triceps skin fold (mm) | 0.3 | 0.04* |
Subscapular skin fold (mm) | 0.3 | 0.04* |
Systolic Bp (mmHg) | 0.7 | 0.000** |
Diastolic Bp (mmHg) | 0.3 | 0.04* |
Cholesterol (mg/dl) | 0.5 | 0.000** |
Triglycerides (mg/dl) | 0.4 | 0.02* |
HDL-c (mg/dl) | 0.3 | 0.08 |
LDL-c (mg/dl) | 0.6 | 0.000** |
FBS (mg/dl) | 0.1 | 0.4 |
Insulin (μIU/ml) | 0.5 | 0.000** |
HOMA-IR | 0.5 | 0.02* |